The AIM-HI Accelerator Fund (AIM-HI) just announced 6 Semi-Finalists for the 2022 AIM-HI Women’s Venture…
2023 Women’s Venture Competition – Application open until Sunday, March 19!
In light of the extenuating weather conditions and power outages in multiple states, the Deadline to Apply for the 2023 AIM-HI Women’s Venture Competition has been extended to Sunday, March 19, at 11:55 PM EST!
Launched by the AIM-HI Accelerator Fund (AIM-HI) in 2020, this competition is designed to accelerate innovative women-led, early-stage oncology companies worldwide. Don’t miss this unique opportunity to apply for up to $1 million in pre-seed, seed, or Series A investment.
In addition to the funding, participating women entrepreneurs will also benefit from an interactive forum to receive constructive feedback, increased visibility, and valuable networking opportunities. Top finalists of the competition will be awarded with cash honorariums and honored with certificates.
All submitted applications will be reviewed and screened by our Selection Committee based on the quality of applications. 6-8 semi-finalists will be chosen and invited to compete in front of a Judging Committee to select finalists who will be awarded honorariums and certificates.
An Investment Committee will conduct detailed due diligence research on the finalists to determine whether an investment will be made based on the technology platform merits, cancer patient impact, and potential for return on investment. The company that passes the due diligence process will receive up to $1 million in investment from AIM-HI and co-investors.
Our three-track Selection, Judging, and Investment Committees consist of world-class life sciences industry professionals, business leaders, and investors.
Learn more and Apply Now!